All In Biotech

Drug Trial Radar · NCT06438263

A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

An Open-label, Phase 1, Single Dose, Randomized, Parallel-group Study to Assess the Relative Bioavailability of Rocatinlimab (AMG 451) Autoinjector and Vial in Healthy Subjects

Last checked: Nov 19, 2026Latest source record: Jan 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 231 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

231

Actual

Start

Aug 6, 2024

Primary completion

May 3, 2025

Study completion Jul 2, 2025

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
May 31, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main objective of this study is to evaluate the pharmacokinetics (PK) of rocatinlimab given as a single subcutaneous (SC) autoinjector dose compared to vial in healthy participants.

Conditions

  • Atopic Dermatitis

Interventions

  • RocatinlimabDrug

    Vial supplied as a single-use preservative free solution for SC injection.

  • RocatinlimabDrug

    Autoinjector for SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum Plasma Concentration (Cmax) of RocatinlimabTime frame: Up to approximately 112 days
  2. Area Under the Serum Concentration-time Curve (AUC) From Time Zero to Time of Last Quantifiable Concentration (AUClast) of RocatinlimabTime frame: Up to approximately 112 days
  3. AUC From Time Zero to Infinity (AUCinf) of RocatinlimabTime frame: Up to approximately 112 days

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Fortrea Clinical Research Unit - Daytona Beach

    Daytona Beach, Florida

  • Fortrea Clinical Research Unit - Dallas

    Dallas, Texas

  • Fortrea Clinical Research Unit Inc. - Madison

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.